0001209191-20-031063.txt : 20200520 0001209191-20-031063.hdr.sgml : 20200520 20200520200755 ACCESSION NUMBER: 0001209191-20-031063 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200518 FILED AS OF DATE: 20200520 DATE AS OF CHANGE: 20200520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BORKAR RATAN S CENTRAL INDEX KEY: 0001720077 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10961 FILM NUMBER: 20899638 MAIL ADDRESS: STREET 1: 12544 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUIDEL CORP /DE/ CENTRAL INDEX KEY: 0000353569 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 942573850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8585521100 MAIL ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/ DATE OF NAME CHANGE: 19910210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-18 0 0000353569 QUIDEL CORP /DE/ QDEL 0001720077 BORKAR RATAN S 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 0 1 0 0 SVP, Intl Comm Operations Common Stock 2020-05-18 4 S 0 1665 196.7752 D 10839 D Common Stock 2020-05-18 4 M 0 1898 21.08 A 12737 D Common Stock 2020-05-18 4 M 0 4606 46.41 A 17343 D Common Stock 2020-05-18 4 M 0 5376 15.40 A 22719 D Common Stock 2020-05-18 4 M 0 4452 41.36 A 27171 D Common Stock 2020-05-18 4 S 0 16332 192.5277 D 10839 D Common Stock 2020-05-18 4 S 0 10315 192.6437 D 524 D Non-Qualified Stock Option 21.08 2020-05-18 4 M 0 1898 0.00 D 2027-02-15 Common Stock 1898 1898 D Non-Qualified Stock Option 46.41 2020-05-18 4 M 0 4606 0.00 D 2028-01-16 Common Stock 4606 4606 D Non-Qualified Stock Option 15.40 2020-05-18 4 M 0 5376 0.00 D 2026-02-10 Common Stock 5376 0 D Non-Qualified Stock Option 41.36 2020-05-18 4 M 0 4452 0.00 D 2027-10-16 Common Stock 4452 4450 D The weighted average sale price for these transactions was $196.7752 per share, with a range of $191.95 to $201.10. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. The weighted average sale price for these transactions was $192.5277 per share, with a range of $185.17 to $201.10. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. The weighted average sale price for these transactions was $192.6437 per share, with a range of $185.17 to $201.10. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. 3,797 shares vested on the second anniversary of the grant date, February 15, 2019. 1,898 shares vested on the third anniversary date of the grant date, February 15, 2020. 1,898 shares will vest on the fourth anniversary date of the grant date, February 15, 2021. 4606 shares vested on the second anniversary of the grant date, January 16, 2020. 2,303 shares will vest on the third anniversary date of the grant date, January 16, 2021. 2,303 shares will vest on the fourth anniversary date of the grant date, January 16, 2022. 10,754 shares vested on the second anniversary date of the grant date, February 10, 2018. 5,376 shares vested on the third anniversary date of the grant date, February 10, 2019. 5,376 shares vested on the fourth anniversary date of the grant date, February 10, 2020. 4,452 shares vested on the second anniversary date of the grant date, October 16, 2019. 2,225 shares will vest on the third anniversary date of the grant date, October 16, 2020. 2,225 shares will vest on the fourth anniversary date of the grant date, October 16, 2021. All transactions reported herein were effected pursuant to a pre-established 10b5-1 trading plan. Robert J. Bujarski, attorney-in-fact for Ratan S. Borkar 2020-05-20